BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23258135)

  • 1. Does reducing unnecessary right ventricular pacing improve sympathetic activity and innervation of heart in sinus node disease patients? MVP and SafeR study.
    Miyamoto M; Kimura Y; Hosoda J; Matsumoto K; Matsushita K; Ishikawa T; Umemura S
    Int Heart J; 2012; 53(6):353-8. PubMed ID: 23258135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
    Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G;
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
    Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S;
    Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of right ventricular pacing in patients with sinus node dysfunction through programming a long atrioventricular delay along with the DDIR mode.
    Nitardy A; Langreck H; Dietz R; Stockburger M
    Clin Res Cardiol; 2009 Jan; 98(1):25-32. PubMed ID: 18853096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near elimination of ventricular pacing in SafeR mode compared to DDD modes: a randomized study of 422 patients.
    Davy JM; Hoffmann E; Frey A; Jocham K; Rossi S; Dupuis JM; Frabetti L; Ducloux P; Prades E; Jauvert G
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):392-402. PubMed ID: 22309303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial.
    Stockburger M; Defaye P; Boveda S; Stancak B; Lazarus A; Sipötz J; Nardi S; Rolando M; Moreno J
    Europace; 2016 May; 18(5):739-46. PubMed ID: 26612882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing right ventricular pacing in patients with sinus node disease and prolonged PQ interval: The impact on exercise capacity.
    Krzyżanowski K; Michałkiewicz D; Orski Z; Wierzbowski R; Ryczek R; Cwetsch A
    Cardiol J; 2015; 22(1):75-9. PubMed ID: 24846513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of automatic mode change between DDD and AAI to facilitate native atrioventricular conduction in patients with sick sinus syndrome or transient atrioventricular block.
    Mayumi H; Kohno H; Yasui H; Kawachi Y; Tokunaga K
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1740-7. PubMed ID: 8945033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale.
    Pastore G; Bertini M; Bonanno C; Coluccia G; Dell'Era G; De Mattia L; Grieco D; Katsouras G; Maines M; Marcantoni L; Marinaccio L; Paglino G; Palmisano P; Ziacchi M; Zoppo F; Noventa F
    Europace; 2023 May; 25(5):. PubMed ID: 36974970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of single-chamber atrial pacing compared with dual-chamber pacing in patients with sinus-node dysfunction and intact atrioventricular node conduction.
    Kim WH; Joung B; Shim J; Park JS; Hwang ES; Pak HN; Kim S; Lee M
    Yonsei Med J; 2010 Nov; 51(6):832-7. PubMed ID: 20879047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population.
    Stockburger M; Boveda S; Moreno J; Da Costa A; Hatala R; Brachmann J; Butter C; Garcia Seara J; Rolando M; Defaye P
    Eur Heart J; 2015 Jan; 36(3):151-7. PubMed ID: 25179761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial pacing site and atrioventricular conduction in patients paced for sinus node disease.
    Watabe T; Abe H; Kohno R; Oginosawa Y; Hayashi K; Ohe H; Tamura M; Takeuchi M; Otsuji Y
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1224-31. PubMed ID: 24946835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.
    Chen S; Wang Z; Kiuchi MG; Andrea BR; Krucoff MW; Liu S; Pürerfellner H
    Clin Res Cardiol; 2016 Aug; 105(8):687-698. PubMed ID: 26913516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrioventricular Interval Extension Is Highly Efficient in Preventing Unnecessary Right Ventricular Pacing in Sinus Node Disease: A Randomized Cross-Over Study Versus Dual- to Atrial Single-Chamber Mode Switch.
    Calvi V; Pisanò EC; Brieda M; Melissano D; Castaldi B; Guastaferro C; Nigro G; Madalosso M; Orsida D; Rovai N; Gargaro A; Capucci A
    JACC Clin Electrophysiol; 2017 May; 3(5):482-490. PubMed ID: 29759604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
    Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential prevention of pacing-induced heart failure using simple pacemaker programming algorithm.
    Chwyczko T; Dąbrowski R; Maciąg A; Sterliński M; Smolis-Bąk E; Borowiec A; Kowalik I; Łabęcka A; Jankowska A; Kośmicki M; Janas J; Pytkowski M; Szwed H
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):369-78. PubMed ID: 23879277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAIR versus DDDR pacing in patients with impaired sinus node chronotropy: an echocardiographic and cardiopulmonary study.
    Vardas PE; Simantirakis EN; Parthenakis FI; Chrysostomakis SI; Skalidis EI; Zuridakis EG
    Pacing Clin Electrophysiol; 1997 Jul; 20(7):1762-8. PubMed ID: 9249829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAIsafeR limits ventricular pacing in unselected patients.
    Pioger G; Leny G; Nitzsché R; Ripart A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S66-70. PubMed ID: 17302721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.